HQL P/E Ratio
P/E Ratio as of Oct 13, 2025: -41.78
Average-38.79
Median-39.38
Minimum-41.78
Maximum-35.97
-41.78
Past Month-5.19 (14.18%)
The P/E ratio for HQL is -41.78 as of Oct 13, 2025. This represents a increase of 409.51% compared to its 12-month average P/E ratio of -8.2. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
abrdn Life Sciences Investors P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
abrdn Life Sciences Investors ’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing abrdn Life Sciences Investors to industry peers.
abrdn Life Sciences Investors P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
abrdn Life Sciences Investors ’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing abrdn Life Sciences Investors to industry peers.
HQL P/E Ratio Insights
See abrdn Life Sciences Investors ’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in HQL
Order type
Buy in
Order amount
Est. shares
0 shares
HQL P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2025 | $15.76 | -40.69 |
| Sep 2, 2025 | $14.06 | -36.30 |
| Aug 1, 2025 | $13.12 | -33.88 |
| Jul 1, 2025 | $12.91 | -33.33 |
| Jun 2, 2025 | $12.31 | 3.99 |
| May 1, 2025 | $12.70 | 4.12 |
| Apr 1, 2025 | $12.34 | 4.00 |
| Mar 3, 2025 | $13.26 | 4.30 |
| Feb 3, 2025 | $14.02 | 4.54 |
| Jan 2, 2025 | $13.23 | 4.29 |
HQL End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -41.78 | -1,083.06% |
| 2024 | 4.25 | -72.77% |
| 2023 | 15.61 | -553.78% |
| 2022 | -3.44 | -147.19% |
| 2021 | 7.29 | +91.84% |
| 2020 | 3.80 | — |
FAQs About abrdn Life Sciences Investors (HQL) P/E ratio
The latest P/E ratio of HQL is -41.78, as of Oct 13, 2025. This is calculated based on its current stock price and earnings per share (EPS).
abrdn Life Sciences Investors ’s last 12-month average P/E ratio is -8.2, compared to its current P/E ratio of -41.78. This reflects a increase of 409.51%.
abrdn Life Sciences Investors ’s current P/E ratio of -41.78 is higher than its last 12-month average P/E of -8.2. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
abrdn Life Sciences Investors ’s average P/E ratio over the last 3 years is 13.31. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
abrdn Life Sciences Investors ’s average P/E ratio over the last 5 years is 8.48. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.